Dan James Fintel

Phone+1 312 695 0993
Emaildfintelnorthwesternedu

h-index
h10-index
h5-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

Research Interests

Anti-thrombotic therapy, Atrial fibrillation, Cardiac stress testing, Cardiovascular critical care, Coronary heart disease, Ischemic heart disease, Nuclear cardiology

Certifications and Licenses

	Internal Medicine
	Cardiovascular Disease

Training Experience

1982	Residency, Mt. Sinai Hospital
1985	Fellowship, Johns Hopkins Hospital

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Education/Academic qualification

MD, Medicine, Harvard University

… → 1979

Research interests

Cardiology
Cardiovascular Diseases
Cardiovascular Imaging
Lipid Disorders

Fingerprint

Dive into the research topics where Dan James Fintel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

17 Finished

Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)
Kho, A. N. & Fintel, D. J.
Chicago Community Trust, Patient-Centered Outcomes Research Institute
7/1/16 → 9/14/18
Project: Research project
Protocol CACZ885M2301: A Randomized, Double-Blind, Placebo-Controlled, Event-Driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-Myocardial Infarction Patients with Elevated hsCRP
Fintel, D. J.
Novartis Pharmaceuticals Corporation
10/11/11 → 10/31/18
Project: Research project
ALERTS (AngeLmed for Early Recognition and Treatment of STEMI) Study
Fintel, D. J.
Angel Medical Systems, Inc.
12/8/10 → 12/8/19
Project: Research project
Prot# P04737: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease: Thrombin Receptor Antagonist in Second
Fintel, D. J.
Schering-Plough Research Institute
9/15/08 → 9/15/14
Project: Research project
Prot# D5130C05262: A Randomized, Double-Blind, Parallel Group, Phase 3, Efficacy and Safety Study of AZD6140 Compared with Clopidogrel for Prevention of Vascular Events in Patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO - A Stud
Fintel, D. J., Benzuly, K. H., Flaherty, J. D. & Lloyd-Jones, D. M.
AstraZeneca Pharmaceuticals LP
8/28/08 → 8/28/11
Project: Research project

38 Article
9 Review article
1 Chapter

Comparative effectiveness of aspirin dosing in cardiovascular disease
Jones, W. S., Mulder, H., Wruck, L. M., Pencina, M. J., Kripalani, S., Muñoz, D., Crenshaw, D. L., Effron, M. B., Re, R. N., Gupta, K., David Anderson, R., Pepine, C. J., Handberg, E. M., Manning, B. R., Jain, S. K., Girotra, S., Riley, D., DeWalt, D. A., Whittle, J., Goldberg, Y. H., & 51 othersRoger, V. L., Hess, R., Benziger, C. P., Farrehi, P., Zhou, L., Ford, D. E., Haynes, K., VanWormer, J. J., Knowlton, K. U., Kraschnewski, J. L., Polonsky, T. S., Fintel, D. J., Ahmad, F. S., McClay, J. C., Campbell, J. R., Bell, D. S., Fonarow, G. C., Bradley, S. M., Paranjape, A., Roe, M. T., Robertson, H. R., Curtis, L. H., Sharlow, A. G., Berdan, L. G., Hammill, B. G., Harris, D. F., Qualls, L. G., Marquis-Gravel, G., Modrow, M. F., Marcus, G. M., Carton, T. W., Nauman, E., Waitman, L. R., Kho, A. N., Shenkman, E. A., McTigue, K. M., Kaushal, R., Masoudi, F. A., Antman, E. M., Davidson, D. R., Edgley, K., Merritt, J. G., Brown, L. S., Zemon, D. N., McCormick, T. E., Alikhaani, J. D., Gregoire, K. C., Rothman, R. L., Harrington, R. A., Hernandez, A. F. & Sandu, O. A., May 27 2021, In: New England Journal of Medicine. 384, 21, p. 1981-1990 10 p.
Research output: Contribution to journal › Article › peer-review
72 Scopus citations
Comparison of Metoprolol Versus Carvedilol After Acute Myocardial Infarction
Outcomes of Beta-blocker Therapy After myocardial INfarction (OBTAIN) Investigators, May 15 2021, In: American Journal of Cardiology. 147, p. 1-7 7 p.
Research output: Contribution to journal › Article › peer-review
3 Scopus citations
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial
Marquis-Gravel, G., Roe, M. T., Robertson, H. R., Harrington, R. A., Pencina, M. J., Berdan, L. G., Hammill, B. G., Faulkner, M., Munõz, D., Fonarow, G. C., Nallamothu, B. K., Fintel, D. J., Ford, D. E., Zhou, L., Daugherty, S. E., Nauman, E., Kraschnewski, J., Ahmad, F. S., Benziger, C. P., Haynes, K., & 24 othersMerritt, J. G., Metkus, T., Kripalani, S., Gupta, K., Shah, R. C., McClay, J. C., Re, R. N., Geary, C., Lampert, B. C., Bradley, S. M., Jain, S. K., Seifein, H., Whittle, J., Roger, V. L., Effron, M. B., Alvarado, G., Goldberg, Y. H., Vanwormer, J. L., Girotra, S., Farrehi, P., McTigue, K. M., Rothman, R., Hernandez, A. F. & Jones, W. S., May 2020, In: JAMA cardiology. 5, 5, p. 598-607 10 p.
Research output: Contribution to journal › Article › peer-review
41 Scopus citations
Utility of the ACE Inhibitor Captopril in Mitigating Radiation-Associated Pulmonary Toxicity in Lung Cancer
Small, W., James, J. L., Moore, T. D., Fintel, D. J., Lutz, S. T., Movsas, B., Suntharalingam, M., Garces, Y. I., Ivker, R., Moulder, J., Pugh, S. & Berk, L. B., 2018, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 4, p. 396-401 6 p.
Research output: Contribution to journal › Article › peer-review
21 Scopus citations
2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (writing committee to develop acute coronary syndromes and coronary artery disease clinical data standards)
Cannon, C. P., Brindis, R. G., Chaitman, B. R., Cohen, D. J., Cross, J. T., Drozda, J. P., Fesmire, F. M., Fintel, D. J., Fonarow, G. C., Fox, K. A., Gray, D. T., Harrington, R. A., Hicks, K. A., Hollander, J. E., Krumholz, H., Labarthe, D. R., Long, J. B., Mascette, A. M., Meyer, C., Peterson, E. D., & 21 othersRadford, M. J., Roe, M. T., Richmann, J. B., Selker, H. P., Shahian, D. M., Shaw, R. E., Sprenger, S., Swor, R., Underberg, J. A., Van De Werf, F., Weiner, B. H., Weintraub, W. S., Hendel, R. C., Roger, V. L., Bozkurt, B., Jacobs, J. P., Lichtman, J. H., Peterson, P. N., Smith, E. E., Tcheng, J. E. & Wang, T., Jun 2013, In: Critical Pathways in Cardiology. 12, 2, p. 65-105 41 p.
Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Dan James Fintel

Personal profile

Research Interests

Certifications and Licenses

Training Experience

Expertise related to UN Sustainable Development Goals

Education/Academic qualification

Research interests

Fingerprint

Network

Dive into details

Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)

Protocol CACZ885M2301: A Randomized, Double-Blind, Placebo-Controlled, Event-Driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-Myocardial Infarction Patients with Elevated hsCRP

ALERTS (AngeLmed for Early Recognition and Treatment of STEMI) Study

Prot# P04737: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease: Thrombin Receptor Antagonist in Second

Prot# D5130C05262: A Randomized, Double-Blind, Parallel Group, Phase 3, Efficacy and Safety Study of AZD6140 Compared with Clopidogrel for Prevention of Vascular Events in Patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO - A Stud

Comparative effectiveness of aspirin dosing in cardiovascular disease

Comparison of Metoprolol Versus Carvedilol After Acute Myocardial Infarction

Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial

Utility of the ACE Inhibitor Captopril in Mitigating Radiation-Associated Pulmonary Toxicity in Lung Cancer

Dan James Fintel

Personal profile

Research Interests

Certifications and Licenses

Training Experience

Expertise related to UN Sustainable Development Goals

Education/Academic qualification

Research interests

Fingerprint

Network

Grants

Research Output